Clinical Trials Directory

Trials / Unknown

UnknownNCT05214261

Laparoscopic-guided TAP Block vs Epidural Analgesia

Laparoscopic-Guided Transversus Abdominis Plane Block Versus Epidural Analgesia in a Colorectal Laparoscopic Surgery. A Protocol for a Randomized Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
210 (estimated)
Sponsor
Oulu University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The LAPTAP trial will provide evidence on preferred post-operative analgesia method in elective laparoscopic colon surgery.

Detailed description

In most previous studies TAP-block has been inserted by anesthesiologist under ultrasound guidance. TAP blockade can alternatively be performed by a surgeon with laparoscopic visual guidance during trocar placement by aiming injection into fascial plane between the internal oblique and transversus abdominis in the midaxillary line and repeated on the contralateral side. There is lack in studies comparing laparoscopic guided TAP-blockade versus epidural pain analgesia in elective laparoscopic colon surgery exist.

Conditions

Interventions

TypeNameDescription
OTHERSafety and efficiency of post operative analgesia between laparoscopic-assisted TAP block and epidural analgesiaPatients in the TAP group will be given a laparoscopic-assisted TAP block with a total of 2mg/kg of 0.25% bupivacaine in the bilateral subcostal region into four spots of the bilateral subcostal region, two on both sides of the lateral abdomen between the anterior iliac spine and lower costal arch. The TAP block is performed after the first trocar placement before the insertion of other trocars and the beginning of the surgical intervention. In the control group epidural catheters will be placed using landmark- and loss-of-resistance techniques while the patient is on the operating table. Infusions of 4ml/h containing 0.125% levobupivacaine and 5.5 μg/mL fentanyl will be started with a CADD Solis VIP-infusion pump at the time of anesthesia induction.

Timeline

Start date
2022-02-01
Primary completion
2024-12-31
Completion
2025-12-31
First posted
2022-01-28
Last updated
2022-01-28

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT05214261. Inclusion in this directory is not an endorsement.